3-iodobenzylguanidine has been researched along with beta-endorphin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruchelt, G; Gupta, D; Handgretinger, R; Kaleva, N; Klingebiel, T; Niethammer, D; Treuner, J; Wollmann, H | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and beta-endorphin
| Article | Year |
|---|---|
Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; beta-Endorphin; Child; Child, Preschool; Enkephalin, Methionine; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Pain; Time Factors | 1991 |